Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 12, 2022 16:01 ET | Source: HTG Molecular Diagnostics, Inc.

HTG Molecular Diagnostics Reports First Quarter 2022 Results

TUCSON, Ariz., May 12, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide...
May 05, 2022 08:00 ET | Source: HTG Molecular Diagnostics, Inc.

HTG Molecular Diagnostics to Announce Q1 2022 Financial Results and Host Conference Call on Thursday, May 12

TUCSON, Ariz., May 05, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide...
April 13, 2022 08:00 ET | Source: HTG Molecular Diagnostics, Inc.

HTG Expands Therapeutics Team

TUCSON, Ariz., April 13, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide...
April 06, 2022 16:05 ET | Source: HTG Molecular Diagnostics, Inc.

HTG Expands Features of Proprietary HTG EdgeSeq Technology

TUCSON, Ariz., April 06, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide...
March 31, 2022 16:50 ET | Source: HTG Molecular Diagnostics, Inc.

HTG Releases Proof-of-Approach Whitepaper Establishing Utility of Transcriptome-Informed Approach to Drug Discovery

TUCSON, Ariz., March 31, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide...
March 29, 2022 16:05 ET | Source: HTG Molecular Diagnostics, Inc.

HTG Molecular Diagnostics Reports Full Year 2021 Results

TUCSON, Ariz., March 29, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide...
March 22, 2022 16:05 ET | Source: HTG Molecular Diagnostics, Inc.

HTG Molecular Diagnostics to Announce Year End 2021 Financial Results and Host Conference Call on Tuesday, March 29

TUCSON, Ariz., March 22, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide...
March 18, 2022 08:00 ET | Source: HTG Molecular Diagnostics, Inc.

HTG Molecular Diagnostics Announces $7.5 Million Private Placement

TUCSON, Ariz., March 18, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that it...
February 03, 2022 16:05 ET | Source: HTG Molecular Diagnostics, Inc.

HTG Names Renowned RNA Expert Dr. Robert Spitale to Therapeutics Scientific Advisory Board

TUCSON, Ariz., Feb. 03, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide...
January 28, 2022 08:00 ET | Source: HTG Molecular Diagnostics, Inc.

HTG Appoints Biopharmaceutical Industry Veteran Christopher Kiritsy to its Board of Directors

TUCSON, Ariz., Jan. 28, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide...